Filing Flows › Comparisons › SCYX vs DCOY
Scynexis vs Decoy Therapeutics: SCYX and DCOY compared
Scynexis is the larger company: $235K of revenue in its latest quarter (Q2 2026) against $228K for Decoy Therapeutics (Q2 2026).
Where the money goes: SCYX and DCOY
Scynexis (SCYX) · Q2 2026
Scynexis, Q2 2026: revenue $235K (-83% year over year), net earnings $7.4M, operating cash flow −$14.9M. The chart follows the revenue to costs, profit and cash.
Decoy Therapeutics (DCOY) · Q2 2026
Decoy Therapeutics, Q2 2026: revenue $228K, net loss $2.4M, operating cash flow −$2.7M. The chart follows the revenue to costs, profit and cash.
| Scynexis (SCYX) | Decoy Therapeutics (DCOY) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $235K | $228K |
| Revenue growth, Y/Y | -83% | — |
| Operating margin | n/m | n/m |
| Net earnings | $7.4M | −$2.4M |
| Operating cash flow | −$14.9M | −$2.7M |
| Market value | $45.0M | — |
| Analysts’ mean target | $36.33 | — |
Questions
Which is bigger, Scynexis or Decoy Therapeutics?
Scynexis is the larger company: $235K of revenue in its latest quarter (Q2 2026) against $228K for Decoy Therapeutics (Q2 2026).
More: Scynexis earnings · how Scynexis makes money · Decoy Therapeutics earnings · how Decoy Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed Aug 12, 2026). Fiscal quarters can end on different dates. Not investment advice.